Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean azd8529 of azd 8539 of azd 8539?
Displaying drugs 26 - 48 of 48 in total

AZD-9684

AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
Investigational
Matched Name: … AZD-9684 …
Matched Description: … AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). …

AZD-8330

AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Investigational
Matched Name: … AZD-8330 …
Matched Description: … AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways ... AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including …

AZD-5991

AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
Investigational
Matched Name: … AZD-5991 …
Matched Description: … AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory …

AZD 3355

AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.
Investigational
Matched Name: … AZD 3355 …
Matched Description: … AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. …

AZD-4017

AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).
Investigational
Matched Name: … AZD-4017 …
Matched Description: … AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability …

AZD-1305

AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation, and Left Ventricle Function.
Investigational
Matched Name: … AZD-1305 …

AZD-5672

Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.
Investigational
Matched Name: … AZD-5672 …

AZD-9164

AZD9164 has been used in trials studying the basic science and treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Name: … AZD-9164 …

AZD-0328

AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.
Investigational
Matched Name: … AZD-0328 …

AZD-6280

AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Matched Name: … AZD-6280 …

AZD-7762

AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.
Investigational
Matched Name: … AZD-7762 …

AZD-5423

AZD5423 has been used in trials studying the basic science and treatment of Asthma, Bioavailability and AUC, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Name: … AZD-5423 …

AZD-2066

AZD2066 has been used in trials studying the treatment and basic science of Pain, Chronic Pain, Reflux Episodes, Neuropathic Pain, and Diabetic Neuropathy, among others.
Investigational
Matched Name: … AZD-2066 …

AZD-7295

AZD7295 has been investigated for the treatment of Hepatitis C.
Investigational
Matched Name: … AZD-7295 …

AZD-7325

AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Investigational
Matched Name: … AZD-7325 …

AZD-9977

AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers).
Investigational
Matched Name: … AZD-9977 …
Matched Description: … AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics …

AZD-1940

Investigational
Matched Name: … AZD-1940 …

AZD8529

AZD8529 is under investigation in clinical trial NCT00921804 (Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients).
Investigational
Matched Name: … AZD8529 …
Matched Description: … Tolerability of AZD8529 in Adult Schizophrenia Patients). ... AZD8529 is under investigation in clinical trial NCT00921804 (Study to Assess the Efficacy, Safety, and …

AZD2066

Investigational

AZD0947

AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder. As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company’s development pipeline.
Investigational

AZD3409

AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.
Investigational

AZD7442

AZD7442 is a combination of SARS-CoV-2 antibodies (AZD8895 + AZD1061) currently undergoing phase I clinical trials for the prevention and treatment of COVID-19. It was developed by AstraZeneca with the goal of conferring at least 6 months of protection against COVID-19 - a significantly longer window of efficacy than that...
Investigational

Golidocitinib

Investigational
Displaying drugs 26 - 48 of 48 in total